Dr. Reddys Laboratories Ltd announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialization of the drug, baricitinib,in India.
- Read more about Dr. Reddys Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access toCOVID-19 Treatment in India
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/dr-reddys-laboratories-enters-into-a-voluntary-licensing-agreement-with-lilly-to-expand-access-tocovid-19-treatment-in-india
No comments:
Post a Comment